ALX Oncology Holdings Inc. (ALXO) analyst actions
Rating and price-target actions on ALXO in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the ALXO overview →
1 measured ALXO analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| ALX Oncology Announces Initiation of Phase 2 Investigator-Sponsored Trial of Neoadjuvant Radiation and Evorpacept in Combination with Pembrolizumab in Patients with Untreated HPV-Mediated Oropharyngeal Cancer | Press release | -0.42% | +1.49% |
Keep exploring
More ALXO: earnings → · SEC filings → · ALXO overview →